2024-12-31 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

This report analyzes Colgate-Palmolive Co (CL), a leading consumer goods company specializing in oral hygiene products, personal care items, and veterinary products.


**1. Performance Comparison with S&P 500 (VOO):**

Colgate-Palmolive's cumulative return of 39.08% significantly underperformed the S&P 500's cumulative return of 115.96% over the analyzed period.  The difference is -76.9%, placing it at the 3.7th percentile of its historical range compared to the S&P 500.  This indicates consistent underperformance relative to the broader market. The provided CAGR data shows fluctuating performance over various periods, sometimes exceeding and sometimes lagging the market.

**2. Recent Price Movement:**

* **Closing Price:** $90.79
* **5-Day Moving Average:** $91.85
* **20-Day Moving Average:** $93.29
* **60-Day Moving Average:** $95.12

The stock price is currently trading below all three moving averages, suggesting a downward trend in the short to medium term.

**3. Technical Indicators and Expected Return:**

* **RSI (36.71):**  Indicates the stock is in oversold territory, suggesting potential for a bounce.
* **PPO (-0.17):** A negative value suggests bearish momentum.
* **Relative Divergence (-1.2):** Shows a recent short-term downward trend.
* **Expected Return (-1225.4%):** This extremely negative figure likely indicates a significant projected underperformance compared to the S&P 500 over a long-term (2+ years) investment horizon, given current market conditions.  It is crucial to understand the methodology behind this calculation to assess its reliability.  A negative expected return of this magnitude raises serious concerns. The high negative number warrants further investigation into the model used for this projection.


**4. Recent Earnings Analysis:**

The latest quarterly results show a relatively stable revenue stream hovering around $5 billion.  EPS has slightly declined from $0.89 in Q2 2024 to $0.9 in Q3 2024, indicating only minor fluctuation.  There is no information provided about whether these figures beat or missed expectations.  The data lacks context regarding market expectations and any significant changes in the company's strategic direction.


**5. Financial Information Analysis:**

* **Revenue:** Revenue has remained relatively consistent, though slightly decreasing recently.
* **Profit Margin:** Profit margins show a slight downward trend, from 61.08% in Q3 2024 to 58.54% in Q3 2023.
* **Equity and ROE:** Equity and Return on Equity (ROE) figures show significant volatility, with extreme values in Q2 2024 (-7866.67% ROE in Q3 2023) indicating potentially unusual accounting practices or extraordinary events needing further investigation. These figures need more context to be properly interpreted.


**6. News and Recent Issues:**

No specific news or recent market outlook or analyst opinions is provided.


**7. Overall Analysis:**

Colgate-Palmolive has significantly underperformed the S&P 500 over the analyzed period. While the RSI suggests potential for a short-term bounce, the negative PPO, negative relative divergence, and the extremely low projected return signal substantial cause for concern. Recent earnings show stable revenue but slightly declining EPS and fluctuating profit margins.  The extremely volatile equity and ROE figures raise serious questions that require further clarification. The lack of recent news and analyst opinions hinders a complete assessment.  The extremely negative long-term expected return (-1225.4%) is a particularly alarming signal and should be thoroughly investigated before any investment decisions are made.  The data provided is insufficient to fully assess the companyâ€™s current financial health and prospects.  Additional financial statements and expert analysis are necessary to make a well-informed investment decision.


**8. Disclaimer:**  This report is for informational purposes only and should not be considered investment advice.  The analysis is based solely on the limited data provided and may not represent a complete picture of Colgate-Palmolive's financial performance and future prospects.  Independent research and consultation with a financial advisor are strongly recommended before making any investment decisions.
